Results 211 to 220 of about 38,224 (253)

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals. [PDF]

Microbiol Spectr
Kimbrough JH, Maher JM, Sader HS, Castanheira M, Mendes RE.   +4 more
europepmc   +1 more source

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. [PDF]

Microbiol Spectr
Santerre Henriksen A, Jeannot K, Oliver A, Perry JD, Pletz MW, Stefani S, Morrissey I, Longshaw C, ARTEMIS Study Investigators.   +8 more
europepmc   +1 more source

Pseudomonas spp., Acinetobacter spp. and Miscellaneous Gram-Negative Bacilli

, 2017
openaire   +1 more source

Acinetobacter spp. in food and drinking water – A review

Food Microbiology, 2021
Acinetobacter spp. has emerged as a pathogen of major public health concern due to their increased resistance to antibiotics and their association with a wide range of nosocomial infections, community-acquired infections and war and natural disaster-related infections.
Carvalheira, Ana, Silva, Joana, Teixeira, Paula   +2 more
openaire   +4 more sources

Enrichment of Acinetobacter spp. from food samples

Food Microbiology, 2016
Relatively little is known about the role of foods in the chain of transmission of acinetobacters and the occurrence of different Acinetobacter spp. in foods. Currently, there is no standard procedure to recover acinetobacters from food in order to gain insight into the food-related ecology and epidemiology of acinetobacters. This study aimed to assess
Carvalheira, Ana, Ferreira, Vânia, Silva, Joana, Teixeira, Paula   +3 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Acinetobacter spp. and the Clinical Environment

Indoor and Built Environment, 2006
Infections associated with Acinetobacter spp. are an increasing problem in hospitals around the world, with many infections being multiply resistant to antibiotics. Acinetobacter spp. are particularly hardy and can survive on dry surfaces for long periods of time. They have also been cultured from the air on hospital wards.
C B Beggs, K G Kerr, A M Snelling
exaly   +2 more sources

Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals

Clinical Microbiology and Infection, 2005
In total, 226 individuals from the community were investigated for faecal carriage of Acinetobacter spp. by broth enrichment culture, followed by growth on blood agar and/or Leeds Acinetobacter Medium (LAM).
L Dijkshoorn, A T Bernards, Alexandr Nemec   +2 more
exaly   +2 more sources

Acinetobacter baumannii and Acinetobacter spp.

2017
Acinetobacter baumannii is a bacterial pathogen increasingly identified in the clinical microbiology laboratory as a cause of infection in humans. Upon microscopic examination, A. baumannii appears as a Gram-negative coccobacillus, and it produces clear colonies when grown on MacConkey agar, indicating its inability to ferment lactose.
Federico Perez, Robert A. Bonomo
openaire   +1 more source